Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy VI: Nursing Management

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Role of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.

JACC. Advances·2025

Same author

Cardiac Considerations in Pregnancy: A Spotlight on Peripartum Cardiomyopathy and Pregnancy-Associated Spontaneous Coronary Dissection.

Obstetrics and gynecology clinics of North America·2025

Same author

Obstetric Medicine in the Modern Era: Managing High-Risk Pregnancies.

Obstetrics and gynecology clinics of North America·2025

Same author

Mitral Valve Infective Endocarditis Complicated by Vegetation Migration to the Common Femoral Artery Bifurcation.

JACC. Case reports·2024

Same author

Pregnancy-Related Mortality Due to Cardiovascular Conditions: Maternal Mortality Review Committees in 32 U.S. States, 2017 to 2019.

JACC. Advances·2024

Same author

Race, hypertensive disorders of pregnancy and outcomes in peripartum cardiomyopathy.

American heart journal·2024

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Noninvasive Electrocardiography in the Perinatal Mouse

Noninvasive Electrocardiography in the Perinatal Mouse

Published on: June 12, 2020

Update on peripartum cardiomyopathy.

Meredith O Cruz¹, Joan Briller, Judith U Hibbard

¹Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Illinois at Chicago, 840 South Wood Street, M/C 808, Chicago, IL 60612, USA. mcruz9@uic.edu

Obstetrics and Gynecology Clinics of North America

|August 6, 2010

Summary

Peripartum cardiomyopathy (PPCM) is a heart condition in women near childbirth with unknown causes. Further research and an international registry are needed to improve diagnosis, treatment, and outcomes for PPCM patients.

More Related Videos

An Intact Pericardium Ischemic Rodent Model

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

Related Experiment Videos

Last Updated: Jun 10, 2026

Noninvasive Electrocardiography in the Perinatal Mouse

Noninvasive Electrocardiography in the Perinatal Mouse

Published on: June 12, 2020

An Intact Pericardium Ischemic Rodent Model

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

Area of Science:

Cardiology
Maternal Health
Heart Failure

Background:

Peripartum cardiomyopathy (PPCM) is a rare form of heart failure.',
Its exact cause remains unknown despite various postulated mechanisms.
PPCM presents a diagnostic challenge, often being a diagnosis of exclusion.

Purpose of the Study:

To review the current understanding of peripartum cardiomyopathy (PPCM).
To discuss PPCM's pathogenesis, risk factors, diagnosis, and management.
To highlight the need for further research and improved treatment strategies.

Main Methods:

Literature review and discussion of existing data on PPCM.
Analysis of diagnostic criteria and current treatment approaches.
Exploration of prognostic factors and the potential of novel therapies.

Main Results:

PPCM pathogenesis is not fully understood, with multiple contributing factors.
Clinical presentation lacks specificity, complicating early diagnosis.
Treatment is primarily supportive, with prognosis linked to cardiac function recovery.

Conclusions:

Randomized controlled trials, particularly for therapies like bromocriptine, are essential.
Establishing an international registry is crucial for better defining and treating PPCM.
Improved understanding and therapeutic strategies are needed to reduce PPCM morbidity and mortality.